MLTX
Price
$7.46
Change
+$0.40 (+5.67%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
455.31M
47 days until earnings call
NUVL
Price
$83.87
Change
+$1.29 (+1.56%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
6.05B
35 days until earnings call
Interact to see
Advertisement

MLTX vs NUVL

Header iconMLTX vs NUVL Comparison
Open Charts MLTX vs NUVLBanner chart's image
MoonLake Immunotherapeutics
Price$7.46
Change+$0.40 (+5.67%)
Volume$173.38K
Capitalization455.31M
Nuvalent
Price$83.87
Change+$1.29 (+1.56%)
Volume$3.98K
Capitalization6.05B
MLTX vs NUVL Comparison Chart in %
Loading...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. NUVL commentary
Oct 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and NUVL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 03, 2025
Stock price -- (MLTX: $7.06 vs. NUVL: $82.58)
Brand notoriety: MLTX and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 357% vs. NUVL: 148%
Market capitalization -- MLTX: $473.72M vs. NUVL: $6.05B
MLTX [@Biotechnology] is valued at $473.72M. NUVL’s [@Biotechnology] market capitalization is $6.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while NUVL’s TA Score has 7 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 5 bearish.
  • NUVL’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -86.91% price change this week, while NUVL (@Biotechnology) price change was +3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.18%. For the same industry, the average monthly price growth was +13.86%, and the average quarterly price growth was +79.28%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+5.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($6.05B) has a higher market cap than MLTX($455M). NUVL YTD gains are higher at: 5.493 vs. MLTX (-86.962). MLTX has higher annual earnings (EBITDA): -196.98M vs. NUVL (-362.01M). NUVL has more cash in the bank: 1.01B vs. MLTX (425M). MLTX (0) and NUVL (0) have equivalent revenues.
MLTXNUVLMLTX / NUVL
Capitalization455M6.05B8%
EBITDA-196.98M-362.01M54%
Gain YTD-86.9625.493-1,583%
P/E RatioN/AN/A-
Revenue00-
Total Cash425M1.01B42%
Total Debt75.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLTXNUVL
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
72%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCJX49.44N/A
N/A
Touchstone Mid Cap C
ITGIX91.86N/A
N/A
VY® T. Rowe Price Growth Equity I
MRGSX24.86N/A
N/A
BlackRock Advantage Global R
FWOCX17.90N/A
N/A
Fidelity Advisor Women's Leadership C
LRAGX16.77N/A
N/A
Lord Abbett International Growth R3

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-1.53%
KALA - MLTX
89%
Closely correlated
-11.11%
XNCR - MLTX
50%
Loosely correlated
+0.85%
NUVL - MLTX
48%
Loosely correlated
-4.51%
LRMR - MLTX
46%
Loosely correlated
+28.48%
NRIX - MLTX
45%
Loosely correlated
+1.73%
More